0.25Open0.25Pre Close0 Volume78 Open Interest74.00Strike Price0.00Turnover2475.74%IV8.09%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.25Extrinsic Value100Contract SizeAmericanOptions Type-0.0986Delta0.0332Gamma320.96Leverage Ratio-176.9867Theta0.0000Rho-31.64Eff Leverage0.0004Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet